Dr. Stephen K. Richardson, MD

Dr. Richardson practices at Dermatology Associates of Tallahassee PA in Tallahassee, Florida.

Dr. Richardson's NPI, 1710918404, was assigned on July 5, 2006. Dr. Richardson graduated from Harvard Medical School in 2001. Dr. Richardson holds Florida license ME98820.

Dr. Richardson's primary practice is Dermatology Associates of Tallahassee PA, at 1707 Riggins Rd, Tallahassee, FL 32308 in Leon County. The practice phone is (850) 877-4134.

Dr. Richardson's primary practice is Dermatology Associates of Tallahassee PA in Tallahassee, Florida. Dr. Richardson is also affiliated with Doctors' Memorial Hospital. The medical group on file is Dermatology Associates of Tallahassee. Dmand AI also links Dr. Richardson to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Richardson practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Richardson's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Richardson is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Richardson's licenses on file in 2 states: Florida and Pennsylvania.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, corns and calluses and facial skin infection among the conditions Dr. Richardson treats.

CMS data shows 8,376 Medicare services from Dr. Richardson across 32 procedure codes in 2024, for 1,616 Medicare patients. Medicare paid $425,252 for them. Every service was in an office.

CMS counts 1,616 Medicare patients who saw Dr. Richardson in 2024. The largest group is 75 to 84, with 692 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 2% are also on Medicaid. Their average risk score is 0.96, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Richardson's median patient age at 71, with 56% women.

In 2024, Dr. Richardson wrote 1,885 Medicare Part D claims for 799 patients. 94% of them were for generic drugs. CMS names the drug for 1,748 of them, across 21 drugs with 11 or more claims each, at $397,974 in total drug cost. In 2023, CMS named 1,717 claims across 21 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Richardson for performance year 2024, reported as part of a group. Dr. Richardson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 785 procedures of skin biopsy by Dr. Richardson, more than 98% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 24 papers to Dr. Richardson, published from 2007 to 2025. 2025 was the busiest year, with 3. The most frequent topics are Skin Neoplasms, Sezary Syndrome and Bexarotene. Dr. Richardson has published most often in Adv Dermatol. Dr. Richardson's most frequent co-authors are Robert Conrad Fuhlbrigge, MD, PhD, Vidya Mani Medepalli, MD and Andras Schaffer, MD.

CMS Open Payments shows 318 general payments to Dr. Richardson from 31 drug and device companies from 2016 to 2025. Debt forgiveness make up the largest share, 84% of the total. ConvaTec Inc. paid the most, $43,342.

Dr. Richardson graduated from Harvard Medical School in 2001.

Dr. Richardson is in network with 10 carriers, including Elevance, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.